Overview

Vitamin B12a Vasoplegic Syndrome

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The study team will evaluate the medication Hydroxocobalamin (B12a) for treatment of low blood pressure after cardiac surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Hydroxocobalamin
Vitamin B 12
Vitamin B Complex
Vitamins